Global Oxytocic Pharmaceuticals Sales Market report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency.

City of Industry, CA -- (SBWire) -- 06/26/2018 --This report studies the global Oxytocic Pharmaceuticals market status and forecast, categorizes the global Oxytocic Pharmaceuticals market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.

The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.

The global Oxytocic Pharmaceuticals market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of % during 2018-2025.

Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/524136/global-oxytocic-pharmaceuticals-sales-market

The major players covered in this report

Fresenius Kaci

Biofutura

Baxter

Pfizer

Ferring

Novartis

Teva

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

Click to view the full report TOC, figure and tables: https://www.qyresearch.com/index/detail/524136/global-oxytocic-pharmaceuticals-sales-market